参考文献
[1] Van DUIN D, LOKJJ, EARLEY M, et al. Colistin VersusCeftazidime-Avibactam in the Treatment of InfectionsDue to Carbapenem-Resistant Enterobacteriaceae. ClinInfect Dis, 2018,66(2):163-171.
[2] ZENG M, XIA J, ZONG Z, et al. Guidelines for thediagnosis, treatment, prevention and control of infectionscaused by carbapenem-resistant gram-negative bacilli[].J Microbiol Immunol Infect, 2023,56(4):653-671.
[3] TAMMA P D, AITKEN S L, BONOMO R A, et al.Infectious Diseases Society of America 2023 Guidance onthe Treatment of Antimicrobial Resistant Gram-NegativeInfectionslll. Clin Infect Dis, 2023.
[4] ZENG M, XIA J, ZONG Z, et al. Guidelines for thediagnosis, treatment, prevention and control of infectionscaused by carbapenem-resistant gram-negative bacillil].J Microbiol Immunol Infect, 2023,56(4):653-671.
[5] LARCHER R, LAFFONT-LOZES P, ROGER C, et al. Lastresort beta-lactam antibiotics for treatment of New-DelhiMetallo-Beta-Lactamase producing Enterobacterales andother Difficult-to-Treat Resistance in Gram-negativebacteria: A real-life study']. Front Cell Infect Microbiol2022,12: 1048633.
[6] HUANG Y S, CHEN P Y, CHOU P C, et al. In VitroActivities and Inoculum Effects of Cefiderocol andAztreonam-Avibactam against Metallo-beta-Lactamase.Producing Enterobacteriaceaelf]. Microbiol Spectr,2023,11(3): e56923.
[7] MONARI C, SPAGNUOLO F, PISATURO M, et al.Bloodstream Infection Due to a VIM-Metallo-beta-Lactamase-Producing Klebsiella pneumoniae Treatedwith Cefiderocol in a Preterm Newborn. Infect DisTher, 2023,12(2):727-734.
[8] Le TERRIER C, NORDMANN P, POIREL L. In vitroactivity of aztreonam in combination with newlydeveloped beta-lactamase inhibitors against MDREnterobacterales and Pseudomonas aeruginosa producingmetallo-beta-lactamases.I Antimicrob Chemother,2022,78(1): 101-107.
[9] 符梦瑜,郑裕彤,周伟全,等,产金屆B-内酰胺酶细菌的治疗药物研究进展[].现代药物与临床,2024,39(02):514-521.
作者：广东省药学会 东莞市第八人民医院 符梦瑜 陈秀会
审阅：广东省药学会 中山大学孙逸仙纪念医院深汕中心医院药学部 王锦秋
编辑：广东省药学会 中山大学孙逸仙纪念医院深汕中心医院药学部 施婷婷
